Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,224
Closed -$178K 1940
2024
Q1
$178K Hold
17,224
﹤0.01% 1659
2023
Q4
$338K Sell
17,224
-7,180
-29% -$125K ﹤0.01% 1509
2023
Q3
$426K Buy
24,404
+10,232
+72% +$257K ﹤0.01% 1437
2023
Q2
$412K Buy
14,172
+8,517
+151% +$234K ﹤0.01% 1427
2023
Q1
$150K Buy
+5,655
New +$145K ﹤0.01% 1647
2022
Q4
Sell
-4,832
Closed -$79K 1922
2022
Q3
$79K Buy
4,832
+2,745
+132% +$61.6K ﹤0.01% 1592
2022
Q2
$50K Buy
+2,087
New +$62.4K ﹤0.01% 1539
2021
Q4
Sell
-2,365
Closed -$227K 1684
2021
Q3
$227K Buy
+2,365
New +$258K ﹤0.01% 1423

Other funds holding CRNC

Amundi's CRNC Position: Q2 2024 in Review

Amundi sold out of Cerence (CRNC) in Q2 2024, closing a stake of 17,224 shares — an estimated $178K sold.

Amundi first reported a position in CRNC in Q3 2021 and held it in 8 quarters. The position peaked at $426K in Q3 2023. 186 funds tracked by Wall St. Rank hold CRNC as of Q2 2024.

  • Amundi reported no remaining Cerence position as of Q2 2024 after selling out during the quarter.
  • Amundi sold 17,224 Cerence shares in Q2 2024, an estimated $178K.
  • Amundi first reported a position in Cerence in Q3 2021 and held it in 8 quarters.
  • Amundi's Cerence position peaked at $426K in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Cerence as of Q2 2024.

Based on Amundi's 13F filing for Q2 2024, filed 14 Aug 2024.